Address And Details

500 Boylston St , Boston, MA 02116
Fund Manager Eric B. Fischman
Manager Tenure 19 Years 5 Months

Strategy And Objective

The fund s investment objective is to seek capital appreciation. MFS (Massachusetts Financial Services Company, the fund s investment adviser) normally invests the fund s assets primarily in equity securities. Equity securities include common stocks and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. MFS focuses on investing the fund s assets in the stocks of companies it believes to have above average earnings growth potential compared to other companies (growth companies). While MFS may invest the fund s assets in securities of companies of any size, MFS primarily invests in securities of companies with large capitalizations. MFS may invest the fund s assets in foreign securities. MFS normally invests the fund s assets across different industries and sectors, but MFS may invest a significant percentage of the fund s assets in issuers in a single industry or sector. MFS uses an active bottom-up investment approach to buying and selling investments for the fund. Investments are selected primarily based on fundamental analysis of individual issuers. Quantitative screening tools that systematically evaluate issuers may also be considered.

Net Asset Value

as of 5:47 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.78%
  • 1 Month
  • +1.97%
  • 3 Months
  • +7.89%
  • 1 Yr Return
  • +24.99%
  • 5 Yr Return
  • +130.96%

Equity Sector Breakdown

Technology 53.06%
RetailTrade 12.46%
Finance 8.20%
NonDurables 6.29%
Services 5.43%
IndustrialCyclical 5.31%
Health 3.29%
ConsumerDurables 0.85%
Utilities 0.79%
Energy n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.29%
ForeignStocks 3.86%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 141.90 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 5.08 5.32 2.15
Beta 0.92 0.92 0.95
R Squared 0.90 0.85 0.86
Std Deviation 18.11 15.00 13.81
Sharpe Ratio 1.28 1.51 n/a

Purchase Information

as of 5:45 PM ET 09/16/2021
Minimum Initial n/a
Minimum Additional $99
Minimum Initial IRA $99

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +24.73%
  • +33.88%
+24.73% +33.88%
3 Year
  • +22.49%
  • +22.07%
+22.49% +22.07%
10 Year
  • +17.90%
  • +16.37%
+17.90% +16.37%
Life Of Fund
  • +11.71%
  • +11.54%
+11.71% +11.54%

Top 10 Holdings

Symbol Company Name % Of Assets
AMZN AMAZON COM INC 8.20%
GOOGL ALPHABET INC CLASS A 5.58%
FB FACEBOOK INC 3.90%
ADBE ADOBE SYSTEMS INC 3.81%
MA MASTERCARD INC 3.34%
V VISA INC 2.82%
PYPL PAYPAL HOLDINGS INC 2.65%
AAPL APPLE INC 2.21%
DHR DANAHER CORP 2.12%
INTU INTUIT INC 2.10%

LATEST NEWS

Recent Articles from TheStreet

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.

Evergrande Group Lead

China Faces 'Lehman Moment' With Evergrande Collapse, So What Are The Risks?

'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.